Platelet activation and growth factor release using electric pulses
US-11464829-B2 · Oct 11, 2022 · US
Platelet-derived growth factor [PDGF]
Platelet-derived growth factor [PDGF] · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/49 |
| Official title | Platelet-derived growth factor [PDGF] |
| Display label | Platelet-derived growth factor [PDGF] |
| Total patents | 91 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 5 |
| 2016 | 10 |
| 2017 | 7 |
| 2018 | 7 |
| 2019 | 12 |
| 2020 | 4 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 9 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Novel peptide, compositions and method for delivery of agents into cells and tissues
US-2022204562-A1 · Jun 30, 2022 · US
Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium
US-2022088143-A1 · Mar 24, 2022 · US
Lymphangiogenesis for therapeutic immunomodulation
US-2022047700-A1 · Feb 17, 2022 · US
Genetically engineered larvae for wound healing
US-11248237-B2 · Feb 15, 2022 · US
Compositions and methods relating to bone repair and regeneration
US-2021401936-A1 · Dec 30, 2021 · US
Reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction
US-11135164-B2 · Oct 5, 2021 · US
Targeting anabolic drugs for accelerated fracture repair
US-2021214408-A1 · Jul 15, 2021 · US
Targeting anabolic drugs for accelerated fracture repair
US-2021213135-A1 · Jul 15, 2021 · US
Targeting anabolic drugs for accelerated fracture repair
US-2021206820-A1 · Jul 8, 2021 · US
Anabolic targeting stem cell gene therapy for osteoporosis
US-2021177908-A1 · Jun 17, 2021 · US
Pharmaceutical composition containing stem cell in which vascular endothelial growth factor is overexpressed as effective ingredient for preventing or treating neurodegenerative disease
US-11007228-B2 · May 18, 2021 · US
Delivery of therapeutic agents by a collagen binding protein
US-11001820-B2 · May 11, 2021 · US
Method for treating melanoma using lymphangiogenesis inducers and a melanoma-specific antigen
US-10980877-B2 · Apr 20, 2021 · US
Heparin composition for treating ischemia
US-2021077522-A1 · Mar 18, 2021 · US
Drug Evaluation Method
US-2020355694-A1 · Nov 12, 2020 · US
Gene transfer systems for stem cell engineering
US-2020207834-A1 · Jul 2, 2020 · US
Agents which inhibit gads dimerization and methods of use thereof
US-2020172604-A1 · Jun 4, 2020 · US
Cosmetic composition for improving skin conditions comprising fusion protein including skin penetration enhancing peptide
US-2020165312-A1 · May 28, 2020 · US
Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium
US-2019358297-A1 · Nov 28, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/49?
- CPC C07K14/49 is the Cooperative Patent Classification code for “Platelet-derived growth factor [PDGF].”
- How many patents are filed under CPC C07K14/49 (Platelet-derived growth factor [PDGF])?
- Our database includes 91 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/49 growing?
- Publication counts under this code: 8 in 2024 vs 8 in 2025 (latest complete years).